Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Sale | -$7.87M | -20K | -0.39% | $393.71 | 5.11M | Feb 29, 2024 | Direct | F1, F2 |
transaction | MEDP | Common Stock | Sale | -$32.2M | -80K | -1.56% | $401.88 | 5.03M | Mar 1, 2024 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.41 to $401.90. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $404.88. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |